Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for Excessive Sleepiness in Shift Work Disorder
NCT01080807Phase 4Completed
- Sponsor
- Cephalon, Inc.
- Start
- Mar 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of armodafinil in shift work sleep disorder (SWSD), sponsored by Cephalon, Inc.. Started Mar 2010; status: completed.
02
Drugs
armodafinil
03
Conditions
shift work sleep disorder (SWSD)
Beyond the preview
Go deeper on NCT01080807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01080807.